Angitia Biopharmaceuticals Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
63
- Latest Deal Type
-
Series D
- Latest Deal Amount
-
$130M
- Investors
-
24
Angitia Biopharmaceuticals General Information
Description
Operator of a global clinical-stage biotechnology company intended for the discovery and development of breakthrough therapies. The company focuses on the research and development of drugs for bone, muscle, and joint diseases, with innovative drugs, enabling patients to recover from severe musculoskeletal diseases.
Contact Information
Website
www.angitiabio.comCorporate Office
- 3027 Townsgate Road
- Suite 220
- Westlake Village, CA 91361
- United States
Corporate Office
- 3027 Townsgate Road
- Suite 220
- Westlake Village, CA 91361
- United States
Angitia Biopharmaceuticals Timeline
Angitia Biopharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series D) | 27-Jan-2026 | $130M | Completed | Clinical Trials - Phase 3 | ||
| 5. Later Stage VC (Series C) | 03-Dec-2024 | Completed | Clinical Trials - Phase 3 | |||
| 4. Later Stage VC (Series B1) | 01-Jan-2024 | Completed | Clinical Trials - Phase 3 | |||
| 3. Early Stage VC (Series B) | 30-Oct-2021 | Completed | Clinical Trials - Phase 2 | |||
| 2. Early Stage VC (Series A) | 17-Aug-2020 | $30M | $45M | Completed | Clinical Trials - Phase 2 | |
| 1. Seed Round | 27-Jun-2018 | $15M | $15M | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Angitia Biopharmaceuticals Comparisons
Industry
Financing
Details
Angitia Biopharmaceuticals Competitors (83)
One of Angitia Biopharmaceuticals’s 83 competitors is Sarepta Therapeutics, a Formerly VC-backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Sarepta Therapeutics | Formerly VC-backed | Cambridge, MA | ||||
| Sangamo Therapeutics | Formerly VC-backed | Richmond, CA | ||||
| Capricor Therapeutics | Formerly VC-backed | San Diego, CA | ||||
| Kolon TissueGene | Corporation | Rockville, MD | ||||
| Aldeyra Therapeutics | Formerly VC-backed | Lexington, MA |
Angitia Biopharmaceuticals Patents
Angitia Biopharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12630651-B2 | Anti-sclerostin constructs and uses thereof | Active | 28-Sep-2020 | ||
| US-20230312755-A1 | Anti-sclerostin constructs and uses thereof | Active | 28-Sep-2020 | ||
| US-20260201071-A1 | Anti-sclerostin constructs and uses thereof | Pending | 28-Sep-2020 | ||
| WO-2022063262-A1 | Anti-sclerostin constructs and uses thereof | Inactive | 28-Sep-2020 | A61P19/00 |
Angitia Biopharmaceuticals Signals
Angitia Biopharmaceuticals Investors (24)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ascenta Capital | Venture Capital | Minority | ||
| BlackRock | Asset Manager | Minority | ||
| BVF Partners | Hedge Fund | Minority | ||
| Frazier Healthcare Partners | PE/Buyout | Minority | ||
| Logos Capital | Hedge Fund | Minority |
Angitia Biopharmaceuticals FAQs
-
When was Angitia Biopharmaceuticals founded?
Angitia Biopharmaceuticals was founded in 2018.
-
Where is Angitia Biopharmaceuticals headquartered?
Angitia Biopharmaceuticals is headquartered in Westlake Village, CA.
-
What is the size of Angitia Biopharmaceuticals?
Angitia Biopharmaceuticals has 63 total employees.
-
What industry is Angitia Biopharmaceuticals in?
Angitia Biopharmaceuticals’s primary industry is Drug Discovery.
-
Is Angitia Biopharmaceuticals a private or public company?
Angitia Biopharmaceuticals is a Private company.
-
What is Angitia Biopharmaceuticals’s current revenue?
The current revenue for Angitia Biopharmaceuticals is .
-
How much funding has Angitia Biopharmaceuticals raised over time?
Angitia Biopharmaceuticals has raised $420M.
-
Who are Angitia Biopharmaceuticals’s investors?
Ascenta Capital, BlackRock, BVF Partners, Frazier Healthcare Partners, and Logos Capital are 5 of 24 investors who have invested in Angitia Biopharmaceuticals.
-
Who are Angitia Biopharmaceuticals’s competitors?
Sarepta Therapeutics, Sangamo Therapeutics, Capricor Therapeutics, Kolon TissueGene, and Aldeyra Therapeutics are some of the 83 competitors of Angitia Biopharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process